Joint venture aims to submit an Investigational New Drug application to the FDA by early next year for treatment that targets solid tumors.
Samgsung Biologics, LegoChem Biosciences Partner on Development of Antibody-Drug Conjugate
You May Also Like
Global Launch Strategies in the Current Political Climate
February 19, 2025
FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk
February 19, 2025
Navigating Distrust: Pharma in the Age of Social Media
February 18, 2025
+ There are no comments
Add yours